Filing Details
- Accession Number:
- 0001203311-17-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-09 19:42:05
- Reporting Period:
- 2017-05-05
- Filing Date:
- 2017-05-09
- Accepted Time:
- 2017-05-09 19:42:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-05 | 100 | $10.29 | 636,535 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-05 | 100 | $63.92 | 636,435 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-05 | 993 | $10.29 | 637,428 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-05 | 993 | $62.82 | 636,435 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-05 | 9,330 | $10.29 | 645,765 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-05 | 9,330 | $61.72 | 636,435 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-05 | 4,039 | $10.20 | 640,474 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-05 | 4,039 | $61.47 | 636,435 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-05-05 | 4,039 | $0.00 | 4,039 | $10.20 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-05-05 | 100 | $0.00 | 100 | $10.29 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-05-05 | 993 | $0.00 | 993 | $10.29 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-05-05 | 9,330 | $0.00 | 9,330 | $10.29 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-05-25 | No | 4 | M | Direct | |
41,582 | 2017-08-28 | No | 4 | M | Direct | |
40,589 | 2017-08-28 | No | 4 | M | Direct | |
31,259 | 2017-08-28 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $62.61 to $63.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $61.54 to $62.42. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $61.38 to $61.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Shares vested at a rate of 25% on 5/25/08 and monthly thereafter until all the shares were fully vested on 5/25/11.
- Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11.